News of Note—Gene therapy to restore sight; umbilical cord cells to repair hearts; studying a Parkinson’s drug in … – FierceBiotech
FierceBiotech |
News of Note—Gene therapy to restore sight; umbilical cord cells to repair hearts; studying a Parkinson’s drug in …
FierceBiotech Researchers at Oxford University used gene therapy to reverse retinitis pigmentosa in mouse models of the disease, which is a common cause of blindness in young people. They delivered a gene that makes the light-sensing protein melanopsin to the … |
|
Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy
Lymphoma News Today Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell therapy for patients with blood cancers who … |
|
Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy
Lymphoma News Today Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell therapy for patients with blood cancers who … |
OncLive |
Immunotherapy in the Peri-Operative Setting of HNSCC
OncLive And I think in the next year, we’re going to get a flurry of safety data on combinations of immunotherapy and radiation that will then empower efficacy design studies to ask, how should we do that? Should it be in combination with platinum and radiation? |